MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the Company will report financial results for its second quarter 2025 ended May 31 on Wednesday, July 9, 2025.
Given the announcement of July 2, 2025, concerning the acquisition of the Company, a conference call will not be held.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care. Further information about Theratechnologies is available on the Company’s website at http://www.theratech.com, on SEDAR+ at http://www.sedarplus.ca and on EDGAR at http://www.sec.gov. Follow Theratechnologies on Linkedin and X.
Contacts:
Get the latest news
delivered to your inbox Sign up for The Manila Times newsletters By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.
Investor inquiries:
Philippe Dubuc
Advertisement
Senior Vice President and Chief Financial Officer
[email protected]
1-438-315-6608
Media inquiries:
Advertisement
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
[email protected]
1-514-336-7800
Advertisement
